The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 17221184 |
55 |
Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates. |
Columbia University |
| 15831442 |
46 |
Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke. |
Taisho Pharmaceutical |
| 11438309 |
51 |
The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. |
Janssen Research Foundation |
| 8935801 |
586 |
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. |
Janssen Research Foundation |
| 2841449 |
9 |
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor. |
Merck Sharp & Dohme Research Laboratories |
| 6248635 |
48 |
Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites. |
Stanford University |
| 3806397 |
13 |
Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. |
University of Arizona |
Search and Browse
